Power Law company profile

Fate Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2007 · IPO 2013 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$18M

Market cap · Apr/2026

Revenue

$6.6M

Latest reported FY

Investors

6 investors on Fate Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Polaris Partners

Venrock

OVP Venture Partners

ARCH Venture Partners

Series B+ 2 investors entered at this stage

Astellas Venture

University of Washington

Global footprint

Where Fate Therapeutics has talent and traffic

AI talent share

0.5% of workforce is AI talent
(1 of 222 staff)

Core AI00%

Other AI10.45%

Non-AI workforce22199.55%

Web traffic by country

7.8K monthly visits
across markets

🇺🇸 United States76.9%

🇮🇳 India11.5%

🇲🇾 Malaysia5.1%

🇪🇸 Spain5.1%

🇯🇵 Japan0%

Top 5 markets shown

Patent intelligence

$53M patent portfolio · 46 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$53M

289.8% of market cap · 38.1× smaller than top peer Ablynx ($2B)

46 active patent families

Where Fate Therapeutics innovates Molecular biologyEffector cellTherapeutic effectCombination therapyCell biology

Above peer median on Market

Quality vs same-sector peers

Fate Therapeutics on the five Patsnap quality dimensions

Fate Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Fate Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Fate Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Fate Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo